The Liver Meeting® is the premier Annual Meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments and the results from pilot and multicenter studies. Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new treatments for patients.
The American Association for the Study of Liver Diseases appreciates your interest in covering The Liver Meeting® and is happy to provide credentialed media with complimentary press registration.
Below you will find a complete listing of the eligibility requirements, guidelines and policies for members of the press who wish to attend The Liver Meeting®. Read all of the sections below carefully, as there have been updates to our policies.
Accepted abstracts are made available to the public on the AASLD website in early October, and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts are available to the public on the AASLD website in November and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00 am ET Friday, November 9.
Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.
AASLD may allow for exceptions, on a case-by-case basis, to the Abstract Embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, General Counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). General statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to AASLD. AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, AASLD requires the company to state in their public disclosure that the complete and final results will be presented at The Liver Meeting®. AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting®.
Public release of a journal article relevant to the abstract will be considered an exception to the Embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.
Journalists and contributing freelancers, employed by a recognized news organization, are eligible to apply for press registration. To be eligible for press registration, media in all categories must be directly involved in the creation of news content for organizations that meet these criteria:
Bloggers will receive press credentials on a case-by-case basis. Please include a link to recent liver disease, hepatology or health care science coverage with your registration for credentials. Finally, all blogs must demonstrate the dissemination of original, editorial news coverage and editorial freedom from advertisers and/or sponsors (single-sponsored blogs will not receive credentials; blogs with advertising must have multiple advertisers clearly identified).
Photographers, videographers, and/or other members of the multimedia team accompanying credentialed news outlets may register as media and provide a link to recent coverage from their team. Further credentialing may be required during the approval process.
NOTE: AASLD has the right to inspect the credentials of anyone registering as media and reserves the right to refuse to register any individual as press.
The following individuals are not eligible for press registration or access to the Newsroom.
NOTE: AASLD prohibits the development of CME content based on information presented at its meetings. CME writers and editors, and those writers and editors working on behalf of organizations that have written CME based on AASLD meetings, are not eligible for press passes.
AASLD will hold a press conference highlighting select research coming out of The Liver Meeting®. This press conference is an opportunity for invited investigators to share their findings with members of the media. Press releases will be sent to registered press under an embargo prior to the start of the meeting.
Press conferences are not open to the public; however, one representative from each company may attend the press conference (which is held in a space distinct from the Newsroom). Company representatives must check in with Newsroom staff 30 minutes prior to the start of the conference and must remain silent through the duration of the conference (i.e., no asking or responding to questions). Additionally, company representatives may not approach media in the press conference room.
Will be announced in October 2018.
Credentialed media have access to all general sessions, the exhibit hall and poster area, the Postgraduate Course and the Basic Science Symposium. Access to pre-conference and other ticketed events with limited enrollment are restricted to ticket holders only. Press wishing to attend these events are encouraged to purchase a ticket.
Filming in The Liver Meeting® Exhibit Hall and poster area is prohibited.
Television and video crews are required to check in immediately at the Newsroom each day.
Television and video crews must wear press badges. Shooting schedules must be provided to AASLD staff in the Newsroom on the first day of the meeting.
Permission of the speaker and moderator must be obtained by the journalist before recording or photographing presentations (including Posters). Artificial light and flash photography cannot be used during presentations. Handheld audio recorders and still cameras are acceptable, assuming that intellectual property copyrights (found in the above tab)are respected.
Under no circumstances may presentations be rebroadcasted.
Any images from the Meeting should be credited to The Liver Meeting® 2018.
Reproduction of materials such as abstract data, posters, presentation slides, etc. requires obtaining permission from the listed author(s) and/or presenter(s) as well as from any individual or group that may hold copyright on the material.
Requests to reproduce excerpts of abstracts or poster presentations must be through the publisher. These requests should be addressed to email@example.com.
Journalists violating copyright may have their press credentials denied the following year.
Insignias and logos of the AASLD, The Liver Meeting® or AASLD Foundation are proprietary marks. Use of these in any fashion, by any entity, for any purpose, is prohibited without the written permission of AASLD. The use of insignias, logos and images that mislead the intended audience to believe that a piece or production is coming from the AASLD is strictly prohibited and will result in the denial of press credentials for future meetings.
If you intend to present coverage of The Liver Meeting® in a dedicated website or newsletter, please include the following disclaimer at the top of your piece: This information is brought to you by [insert organization name] and is not sponsored by, nor a part of, the American Association for the Study of Liver Diseases or The Liver Meeting®. Additionally, you may not use the AASLD or The Liver Meeting® logos or names to imply affiliation.
AASLD reserves the right to request promotional activities violating this policy be edited or removed. Failure to comply with these guidelines may result in loss of press credentials for future meetings.